| (+)-CBI-CDPI1 |
|
|
|
|
|
|
|
|
|
| (+)-CBI-CDPI2 |
|
|
|
|
|
|
|
|
|
| (1-OH)-Exatecan |
|
|
|
|
|
|
|
|
|
| (1R,9S)-Dxd |
|
|
|
|
|
|
|
|
|
| (1R,9S)-Exatecan |
|
|
|
|
|
|
|
|
|
| (4-NH2)-Exatecan |
|
|
|
|
|
|
|
|
99.93% |
| (4-NH2)-Exatecan-d5 |
|
|
|
|
|
|
|
|
98.62% |
| (5-Cl)-DXd |
|
|
|
|
|
|
|
|
|
| (5-Cl)-Exatecan |
|
|
|
|
|
|
|
|
|
| (5-Cl)-Exatecan TFA |
|
|
|
|
|
|
|
|
|
| (9R)-Exatecan |
|
|
|
|
|
|
|
|
|
| (R)-(4-NH2)-Exatecan |
|
|
|
|
|
|
|
|
|
| (R)-Benzyl 2-cyclopropyl-2-hydroxyacetate |
|
|
|
|
|
|
|
|
98.65% |
| (R)-Exatecan Intermediate 1 |
|
|
|
|
|
|
|
|
|
| (R)-Methotrexate-d3 |
|
|
|
|
|
|
|
|
|
| (R)-thioxo-Dxd |
|
|
|
|
|
|
|
|
|
| MMAF intermediate 2 |
|
|
|
|
|
|
|
|
99.97% |
| Taltobulin intermediate-4 |
|
|
|
|
|
|
|
|
99.86% |
| (S,S)-D211 |
|
|
|
|
|
|
|
|
|
| (αR)-Cyclopropaneacetamide-Exatecan |
|
|
|
|
|
|
|
|
99.93% |
| 10-Methoxycamptothecin |
|
|
|
|
|
|
|
|
98.06% |
| 10NH2-11F-Camptothecin |
|
|
|
|
|
|
|
|
|
| 10NH2-11F-Camptothecin TFA |
|
|
|
|
|
|
|
|
|
| 17-AEP-GA |
|
|
|
|
|
|
|
|
|
| 17-GMB-APA-GA |
|
|
|
|
|
|
|
|
|
| (rac)-Exatecan Intermediate 1 |
|
|
|
|
|
|
|
|
99.97% |
| 7-Aminomethyl-10-methyl-11-fluoro camptothecin |
|
|
|
|
|
|
|
|
99.24% |
| 7-Aminomethyl-10-methyl-11-fluoro camptothecin TFA |
|
|
|
|
|
|
|
|
96.52% |
| 7-Hydroxymethyl-10,11-MDCPT |
|
|
|
|
|
|
|
|
|
| 7-Hydroxymethyl-10,11-MDCPT-d5 |
|
|
|
|
|
|
|
|
98.03% |
| 7-MAD-MDCPT |
|
|
|
|
|
|
|
|
98.85% |
| 7-MAD-MDCPT hydrochloride |
|
|
|
|
|
|
|
|
|
| 7-MAD-MDCPT TFA |
|
|
|
|
|
|
|
|
|
| 7-MAD-MDCPT-AC-(s-cyclopropane) |
|
|
|
|
|
|
|
|
|
| 7-MAD-MDCPT-AC-(s-cyclopropane)-d2 |
|
|
|
|
|
|
|
|
|
| 7-Methoxy-9-methylfuro[2,3-b]-quinoline-4,5,8(9H)-trione |
|
|
|
|
|
|
|
|
|
| 7-Methylol-9-methoxy-10-F-camptothecin |
|
|
|
|
|
|
|
|
|
| 7-Epi 10-desacetyl paclitaxel |
|
|
|
|
|
|
|
|
99.76% |
| 7Ethanol-10NH2-11F-Camptothecin |
|
|
|
|
|
|
|
|
|
| Ac-Exatecan |
|
|
|
|
|
|
|
|
99.02% |
| Ac-Exatecan-d5 |
|
|
|
|
|
|
|
|
99.93% |
| AGD-0182 |
|
|
|
|
|
|
|
|
|
| Agrochelin |
|
|
|
|
|
|
|
|
|
| Akt/ROCK-IN-1 |
|
|
|
|
|
|
|
|
|
| Aldoxorubicin |
|
|
|
|
|
|
|
|
95.56% |
| Aldoxorubicin hydrochloride |
|
|
|
|
|
|
|
|
|
| α-Amanitin |
|
|
|
|
|
|
|
|
95.90% |
| Aminohexylgeldanamycin |
|
|
|
|
|
|
|
|
99.82% |
| Aminohexylgeldanamycin hydrochloride |
|
|
|
|
|
|
|
|
|
| Aniline-MPB-amino-C3-PBD |
|
|
|
|
|
|
|
|
|
| Anti-CCL2 (Carlumab)-MC-Vc-PAB-DMEA-PEG2-Duocarmycin SA |
|
|
|
|
|
|
|
|
|
| Anticancer agent 81 |
|
|
|
|
|
|
|
|
|
| Antitumor agent-203 |
|
|
|
|
|
|
|
|
99.07% |
| Auristatin E |
|
|
|
|
|
|
|
|
|
| Auristatin E-d8 |
|
|
|
|
|
|
|
|
99.48% |
| Auristatin F-d8 |
|
|
|
|
|
|
|
|
99.82% |
| Auristatin S |
|
|
|
|
|
|
|
|
|
| AXC-666 |
|
|
|
|
|
|
|
|
99.75% |
| AXC-879 |
|
|
|
|
|
|
|
|
|
| Azonafide-PEABA |
|
|
|
|
|
|
|
|
|
| Bac5(1-25) |
|
|
|
|
|
|
|
|
|
| BCPT02 |
|
|
|
|
|
|
|
|
99.70% |
| Benzyl DC-81 |
|
|
|
|
|
|
|
|
95.80% |
| Beruzatatug |
|
|
|
|
|
|
|
|
99.06% |
| BTK degrader-1 |
|
|
|
|
|
|
|
|
98.72% |
| C-11 |
|
|
|
|
|
|
|
|
|
| Camptothecin derivative-3 |
|
|
|
|
|
|
|
|
99.90% |
| CC-885-CH2-PEG1-NH-CH3 |
|
|
|
|
|
|
|
|
98.52% |
| CC-885-CH2-PEG1-NH-CH3 TFA |
|
|
|
|
|
|
|
|
98.52% |
| Corixetan |
|
|
|
|
|
|
|
|
|
| Cryptophycin analog 1 |
|
|
|
|
|
|
|
|
|
| Cy3.5 maleimide |
|
|
|
|
|
|
|
|
|
| Cyclopropaneacetamide-Exatecan |
|
|
|
|
|
|
|
|
99.60% |
| Dap-NE |
|
|
|
|
|
|
|
|
99.49% |
| Daun02 |
|
|
|
|
|
|
|
|
98.72% |
| Daunorubicin-13C,d3 |
|
|
|
|
|
|
|
|
|
| DC0-NH2 |
|
|
|
|
|
|
|
|
|
| DC1 |
|
|
|
|
|
|
|
|
|
| DC10SMe |
|
|
|
|
|
|
|
|
|
| DC1SMe |
|
|
|
|
|
|
|
|
98.0% |
| DC4 |
|
|
|
|
|
|
|
|
|
| DC41 |
|
|
|
|
|
|
|
|
|
| DC41SMe |
|
|
|
|
|
|
|
|
|
| DC44SMe |
|
|
|
|
|
|
|
|
|
| DC4SMe |
|
|
|
|
|
|
|
|
|
| DeBoc-Cabazitaxel |
|
|
|
|
|
|
|
|
95% |
| Debotansine |
|
|
|
|
|
|
|
|
|
| Decyclohexanamine-Exatecan |
|
|
|
|
|
|
|
|
98.38% |
| Dexamethasone |
|
|
|
|
|
|
|
|
|
| DGN462 |
|
|
|
|
|
|
|
|
|
| Di(MMY-SJG)-Ph-prop-2-yne-1-sulfonic acid |
|
|
|
|
|
|
|
|
|
| Diacetyl Agrochelin |
|
|
|
|
|
|
|
|
|
| Dideoxy-amanitin |
|
|
|
|
|
|
|
|
|
| Dimethyl-SGD-1882 |
|
|
|
|
|
|
|
|
|
| DM1-SMe |
|
|
|
|
|
|
|
|
99.08% |
| DM3 |
|
|
|
|
|
|
|
|
95.59% |
| DM3-SMe |
|
|
|
|
|
|
|
|
|
| DM4 |
|
|
|
|
|
|
|
|
99.64% |
| DM4-d6 |
|
|
|
|
|
|
|
|
99.11% |
| DM4-SMe |
|
|
|
|
|
|
|
|
99.99% |
| DMEA-PNU-159682 |
|
|
|
|
|
|
|
|
|
| DMEA-PNU-159682 dichloroacetate |
|
|
|
|
|
|
|
|
|
| Dolastatin 15 |
|
|
|
|
|
|
|
|
|
| Dov-Val-Dil-OH |
|
|
|
|
|
|
|
|
|
| Dox-btn2 |
|
|
|
|
|
|
|
|
98.80% |
| DRF-1042 |
|
|
|
|
|
|
|
|
98.33% |
| DUBA |
|
|
|
|
|
|
|
|
|
| Duocarmycin A |
|
|
|
|
|
|
|
|
|
| Duocarmycin analog-1 |
|
|
|
|
|
|
|
|
95.85% |
| Duocarmycin DM |
|
|
|
|
|
|
|
|
99.15% |
| Duocarmycin DM free base |
|
|
|
|
|
|
|
|
99.69% |
| Duocarmycin SA |
|
|
|
|
|
|
|
|
99.89% |
| Duocarmycin TM |
|
|
|
|
|
|
|
|
99.82% |
| Duostatin 5 |
|
|
|
|
|
|
|
|
99.76% |
| Duostatin 5-13C,d3 |
|
|
|
|
|
|
|
|
|
| DXd |
|
|
|
|
|
|
|
|
99.30% |
| DXd-d5 |
|
|
|
|
|
|
|
|
99.57% |
| E104 |
|
|
|
|
|
|
|
|
99.38% |
| EBET-1593 |
|
|
|
|
|
|
|
|
|
| Eg5-IN-2 |
|
|
|
|
|
|
|
|
|
| eIF4A-IN-2 |
|
|
|
|
|
|
|
|
|
| Exatecan analog 13 |
|
|
|
|
|
|
|
|
|
| Exatecan analog 36 |
|
|
|
|
|
|
|
|
98.71% |
| Exatecan analog 38 |
|
|
|
|
|
|
|
|
|
| Exatecan analogue 1 |
|
|
|
|
|
|
|
|
|
| Exatecan hydrochloride |
|
|
|
|
|
|
|
|
|
| Exatecan Intermediate 1-d2 |
|
|
|
|
|
|
|
|
|
| Exatecan intermediate 10 |
|
|
|
|
|
|
|
|
99.91% |
| Exatecan intermediate 11 |
|
|
|
|
|
|
|
|
|
| Exatecan intermediate 12 |
|
|
|
|
|
|
|
|
98.17% |
| Exatecan Intermediate 2 |
|
|
|
|
|
|
|
|
99.99% |
| Exatecan Intermediate 2 hydrochloride |
|
|
|
|
|
|
|
|
99.94% |
| Exatecan Intermediate 3 |
|
|
|
|
|
|
|
|
99.83% |
| Exatecan Intermediate 4 |
|
|
|
|
|
|
|
|
98.95% |
| Exatecan Intermediate 4 dihydrochloride |
|
|
|
|
|
|
|
|
99.92% |
| Exatecan Intermediate 7 |
|
|
|
|
|
|
|
|
|
| Exatecan intermediate 8 |
|
|
|
|
|
|
|
|
|
| Exatecan intermediate 9 |
|
|
|
|
|
|
|
|
|
| Exatecan mesylate |
|
|
|
|
|
|
|
|
|
| Exatecan-2-(aminomethoxy)acetamide-Gly-Fmoc |
|
|
|
|
|
|
|
|
|
| Exatecan-3-amine |
|
|
|
|
|
|
|
|
|
| Exatecan-amide-bicyclo[1.1.1]pentan-1-ol |
|
|
|
|
|
|
|
|
|
| Exatecan-amide-bicyclo[1.1.1]pentan-1-ylmethanol |
|
|
|
|
|
|
|
|
|
| Exatecan-amide-CH2-O-CH2-CH2-OH |
|
|
|
|
|
|
|
|
|
| Exatecan-amide-cyclopropanol |
|
|
|
|
|
|
|
|
98.57% |
| Exatecan-methylacetamide-OH |
|
|
|
|
|
|
|
|
97.30% |
| FD236 |
|
|
|
|
|
|
|
|
|
| FL118-14-Propanol |
|
|
|
|
|
|
|
|
99.56% |
| FL118-14-Propanol-d5 |
|
|
|
|
|
|
|
|
97.86% |
| Fmoc-MMAE |
|
|
|
|
|
|
|
|
99.35% |
| Fmoc-MMAF-OMe |
|
|
|
|
|
|
|
|
98.58% |
| Fmoc-PEG6-VCP-Eribulin |
|
|
|
|
|
|
|
|
|
| Fmoc-Val-Lys-PAB-Exatecan |
|
|
|
|
|
|
|
|
|
| Glucocorticoid receptor agonist-1 |
|
|
|
|
|
|
|
|
95.65% |
| Glucocorticoid receptor agonist-2 |
|
|
|
|
|
|
|
|
95.46% |
| Glucocorticoid receptor agonist-3 |
|
|
|
|
|
|
|
|
98.46% |
| Glucocorticoid receptor agonist-4 |
|
|
|
|
|
|
|
|
99.80% |
| Glucocorticoid receptor agonist-5 |
|
|
|
|
|
|
|
|
98.36% |
| Glucocorticoid receptor agonist-6 |
|
|
|
|
|
|
|
|
|
| Gly-7-MAD-MDCPT |
|
|
|
|
|
|
|
|
|
| Gly-7-MAD-MDCPT hydrochloride |
|
|
|
|
|
|
|
|
98.27% |
| Gly-7-MAD-MDCPT TFA |
|
|
|
|
|
|
|
|
|
| Gly-Cyclopropane-Exatecan |
|
|
|
|
|
|
|
|
|
| Glycyl-Exatecan-d5 hydrochloride |
|
|
|
|
|
|
|
|
98.97% |
| Hemiasterlin derivative-1 |
|
|
|
|
|
|
|
|
|
| Hydrotecan |
|
|
|
|
|
|
|
|
99.33% |
| INX-SM-56 |
|
|
|
|
|
|
|
|
99.47% |
| INX-SM-6 |
|
|
|
|
|
|
|
|
98.80% |
| Isofistularin-3 |
|
|
|
|
|
|
|
|
|
| L2H2-6OTD |
|
|
|
|
|
|
|
|
|
| LD2-3 |
|
|
|
|
|
|
|
|
|
| Luisol A |
|
|
|
|
|
|
|
|
99.91% |
| Mal-amido-VA-PAB-α-Amanitin |
|
|
|
|
|
|
|
|
|
| Mal-Exatecan |
|
|
|
|
|
|
|
|
99.39% |
| Maytansinoid B |
|
|
|
|
|
|
|
|
95.87% |
| Maytansinoid DM4 |
|
|
|
|
|
|
|
|
|
| MC-DOXHZN |
|
|
|
|
|
|
|
|
|
| MC-DOXHZN hydrochloride |
|
|
|
|
|
|
|
|
98.0% |
| Mensacarcin |
|
|
|
|
|
|
|
|
|
| Mertansine |
|
|
|
|
|
|
|
|
99.75% |
| Mertansine-d3 |
|
|
|
|
|
|
|
|
|
| MMAD |
|
|
|
|
|
|
|
|
98.94% |
| MMAD-d8 |
|
|
|
|
|
|
|
|
98.95% |
| MMAE-d8 |
|
|
|
|
|
|
|
|
99.15% |
| MMAF |
|
|
|
|
|
|
|
|
99.97% |
| MMAF |
|
|
|
|
|
|
|
|
|
| MMAF hydrochloride |
|
|
|
|
|
|
|
|
99.97% |
| MMAF intermediate 1 |
|
|
|
|
|
|
|
|
99.20% |
| MMAF sodium |
|
|
|
|
|
|
|
|
|
| MMAF sodium |
|
|
|
|
|
|
|
|
99.59% |
| MMAF-d8 hydrochloride |
|
|
|
|
|
|
|
|
99.52% |
| MMAF-methyl ester |
|
|
|
|
|
|
|
|
|
| MMAF-OMe |
|
|
|
|
|
|
|
|
96.05% |
| MMAF-OtBu |
|
|
|
|
|
|
|
|
99.83% |
| Monomethyl auristatin E |
|
|
|
|
|
|
|
|
101.1% |
| Monomethyl auristatin E |
|
|
|
|
|
|
|
|
|
| Monomethyl auristatin E intermediate-14 |
|
|
|
|
|
|
|
|
98.55% |
| Monomethyl auristatin E intermediate-16 |
|
|
|
|
|
|
|
|
|
| Muscotoxin A |
|
|
|
|
|
|
|
|
|
| Mytoxin B |
|
|
|
|
|
|
|
|
|
| MYX1715 |
|
|
|
|
|
|
|
|
99.55% |
| MYX1715 analog 1 |
|
|
|
|
|
|
|
|
|
| Exatecan Intermediate 5 |
|
|
|
|
|
|
|
|
99.90% |
| Exatecan Intermediate 6 |
|
|
|
|
|
|
|
|
99.45% |
| N-Ac-γ-Calicheamicin-AcBut-NHS ester |
|
|
|
|
|
|
|
|
95.62% |
| N-Acetyl-Calicheamicin |
|
|
|
|
|
|
|
|
99.17% |
| N-Me-L-Ala-maytansinol |
|
|
|
|
|
|
|
|
99.89% |
| N-MeVal-Val-Dil-Dap-2-(pyridin-3-yl)ethanamine |
|
|
|
|
|
|
|
|
|
| Nampt-IN-10 |
|
|
|
|
|
|
|
|
|
| Nampt-IN-13 |
|
|
|
|
|
|
|
|
|
| NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT |
|
|
|
|
|
|
|
|
98.71% |
| NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT hydrochloride |
|
|
|
|
|
|
|
|
98.46% |
| NH2-methylpropanamide-Exatecan TFA |
|
|
|
|
|
|
|
|
|
| NMS-P528 |
|
|
|
|
|
|
|
|
|
| NMT-IN-7 |
|
|
|
|
|
|
|
|
99.25% |
| NVP-BQS481 |
|
|
|
|
|
|
|
|
|
| O-Me Eribulin |
|
|
|
|
|
|
|
|
|
| Paclitaxel ceribate |
|
|
|
|
|
|
|
|
|
| Paclitaxel-13C6 |
|
|
|
|
|
|
|
|
|
| PBD derivative-1 |
|
|
|
|
|
|
|
|
|
| PBD dimer-2 |
|
|
|
|
|
|
|
|
98.01% |
| PBD dimer-4 |
|
|
|
|
|
|
|
|
|
| PBD-monoamide |
|
|
|
|
|
|
|
|
96.41% |
| PBX-7016 |
|
|
|
|
|
|
|
|
|
| PE-E2K |
|
|
|
|
|
|
|
|
|
| PF-06380101 |
|
|
|
|
|
|
|
|
99.95% |
| PF-06380101-d8 |
|
|
|
|
|
|
|
|
99.27% |
| PI3K/mTOR-IN-21 |
|
|
|
|
|
|
|
|
|
| PI3K/PIKK-IN-1 |
|
|
|
|
|
|
|
|
|
| PL-13 |
|
|
|
|
|
|
|
|
|
| PNU-159682 |
|
|
|
|
|
|
|
|
98.58% |
| PNU-159682 |
|
|
|
|
|
|
|
|
|
| PNU-159682 carboxylic acid |
|
|
|
|
|
|
|
|
|
| Polyketomycin |
|
|
|
|
|
|
|
|
|
| ProAlk01 |
|
|
|
|
|
|
|
|
|
| PROTAC BRD4 Degrader-5-CO-PEG3-N3 |
|
|
|
|
|
|
|
|
99.73% |
| PY-4Car2 |
|
|
|
|
|
|
|
|
|
| Py-MPB-amino-C3-PBD |
|
|
|
|
|
|
|
|
|
| Rebeccamycin |
|
|
|
|
|
|
|
|
|
| Rezetecan |
|
|
|
|
|
|
|
|
99.60% |
| RNA polymerase II-IN-2 |
|
|
|
|
|
|
|
|
|
| RSL3-NH2 |
|
|
|
|
|
|
|
|
|
| RSL3-NH2 hydrochloride |
|
|
|
|
|
|
|
|
|
| S-Me-DM4 |
|
|
|
|
|
|
|
|
99.94% |
| S-methyl DM1 |
|
|
|
|
|
|
|
|
99.57% |
| SC209 |
|
|
|
|
|
|
|
|
98.99% |
| SC209 intermediate-2 |
|
|
|
|
|
|
|
|
|
| seco-CBI dimer |
|
|
|
|
|
|
|
|
|
| seco-CBI-PBD dimer |
|
|
|
|
|
|
|
|
|
| Seco-DUBA |
|
|
|
|
|
|
|
|
95.37% |
| Seco-DUBA hydrochloride |
|
|
|
|
|
|
|
|
|
| Seco-Duocarmycin SA |
|
|
|
|
|
|
|
|
|
| Seco-Duocarmycin TM |
|
|
|
|
|
|
|
|
|
| SG2057 |
|
|
|
|
|
|
|
|
99.93% |
| SG3199 |
|
|
|
|
|
|
|
|
98.33% |
| SG3199-d6 |
|
|
|
|
|
|
|
|
|
| SGD-1882 |
|
|
|
|
|
|
|
|
95.29% |
| SJG-136 |
|
|
|
|
|
|
|
|
99.47% |
| SJG-136 intermediate-1 |
|
|
|
|
|
|
|
|
99.95% |
| SJG-136 intermediate-2 |
|
|
|
|
|
|
|
|
|
| SN-38 |
|
|
|
|
|
|
|
|
99.94% |
| SN-38-13C6 |
|
|
|
|
|
|
|
|
|
| SN-38-d3 |
|
|
|
|
|
|
|
|
98.79% |
| STING agonist-18 |
|
|
|
|
|
|
|
|
99.84% |
| STING agonist-18 diTFA |
|
|
|
|
|
|
|
|
|
| STING agonist-49 |
|
|
|
|
|
|
|
|
|
| Suicin 65 |
|
|
|
|
|
|
|
|
|
| sulfo-DGN462 sodium |
|
|
|
|
|
|
|
|
|
| T01-1 |
|
|
|
|
|
|
|
|
99.87% |
| T01-1-d5 |
|
|
|
|
|
|
|
|
|
| Taltobulin |
|
|
|
|
|
|
|
|
99.82% |
| Taltobulin hydrochloride |
|
|
|
|
|
|
|
|
99.34% |
| Taltobulin intermediate-8 |
|
|
|
|
|
|
|
|
98.07% |
| Taltobulin trifluoroacetate |
|
|
|
|
|
|
|
|
|
| TAM470 |
|
|
|
|
|
|
|
|
95.64% |
| TAM557 |
|
|
|
|
|
|
|
|
|
| TAM558 intermediate-2 |
|
|
|
|
|
|
|
|
|
| TAM558 intermediate-5 |
|
|
|
|
|
|
|
|
95.08% |
| TH1338 |
|
|
|
|
|
|
|
|
98.77% |
| thioxo-Dxd |
|
|
|
|
|
|
|
|
|
| TLR7 agonist 29 |
|
|
|
|
|
|
|
|
|
| TLR7 agonist 32 |
|
|
|
|
|
|
|
|
|
| TNF-α agonistic 2 |
|
|
|
|
|
|
|
|
|
| Tomaymycin DM |
|
|
|
|
|
|
|
|
95.73% |
| Top1 inhibitor 1 |
|
|
|
|
|
|
|
|
99.67% |
| Topi MF-6 |
|
|
|
|
|
|
|
|
99.79% |
| Tubulin polymerization-IN-38 |
|
|
|
|
|
|
|
|
|
| Tubulysin |
|
|
|
|
|
|
|
|
99.60% |
| Tubulysin A |
|
|
|
|
|
|
|
|
99.56% |
| Tubulysin IM-1 |
|
|
|
|
|
|
|
|
|
| Tubulysin IM-2 |
|
|
|
|
|
|
|
|
|
| Tubulysin IM-3 |
|
|
|
|
|
|
|
|
|
| U-031 |
|
|
|
|
|
|
|
|
|
| Z52 |
|
|
|
|
|
|
|
|
95.76% |
| Z56 |
|
|
|
|
|
|
|
|
|
| ZD06519 |
|
|
|
|
|
|
|
|
98.88% |
| β-Amanitin |
|
|
|
|
|
|
|
|
92.9% |
| γ-Amanitin |
|
|
|
|
|
|
|
|
90.0% |
| ε-Amanitin |
|
|
|
|
|
|
|
|
|
| Fluticasone propionate |
|
|
|
|
|
|
|
|
99.93% |
| Mitomycin C |
|
|
|
|
|
|
|
|
99.85% |
| Exatecan-d3 mesylate |
|
|
|
|
|
|
|
|
|
| Exatecan |
|
|
|
|
|
|
|
|
99.78% |
| Exatecan Intermediate 1 |
|
|
|
|
|
|
|
|
100.1% |
| Exatecan Intermediate 1-d5 |
|
|
|
|
|
|
|
|
99.90% |
| Exatecan-d5 mesylate |
|
|
|
|
|
|
|
|
99.83% |
| Exatecan mesylate |
|
|
|
|
|
|
|
|
101.1% |
| Exatecan mesylate dihydrate |
|
|
|
|
|
|
|
|
|
| Duocarmycin GA |
|
|
|
|
|
|
|
|
99.00% |
| Duocarmycin MA |
|
|
|
|
|
|
|
|
|
| Duocarmycin MB |
|
|
|
|
|
|
|
|
|
| Calicheamicin |
|
|
|
|
|
|
|
|
98.06% |
| Hemiasterlin |
|
|
|
|
|
|
|
|
99.90% |
| Camptothecin |
|
|
|
|
|
|
|
|
99.77% |
| Camptothecin-d5 |
|
|
|
|
|
|
|
|
99.61% |
| Dexamethasone |
|
|
|
|
|
|
|
|
99.86% |
| Dexamethasone-d3-1 |
|
|
|
|
|
|
|
|
98.02% |
| Ansamitocin P-3 |
|
|
|
|
|
|
|
|
98.0% |
| Dolastatin 10 |
|
|
|
|
|
|
|
|
98.34% |
| Sandramycin |
|
|
|
|
|
|
|
|
|
| Budesonide-d6 |
|
|
|
|
|
|
|
|
|
| Budesonide |
|
|
|
|
|
|
|
|
99.81% |
| Tubulysin C |
|
|
|
|
|
|
|
|
|
| Tubulysin D |
|
|
|
|
|
|
|
|
|
| Tubulysin E |
|
|
|
|
|
|
|
|
|
| Tubulysin F |
|
|
|
|
|
|
|
|
|
| Tubulysin G |
|
|
|
|
|
|
|
|
|
| Tubulysin H |
|
|
|
|
|
|
|
|
|
| Tubulysin I |
|
|
|
|
|
|
|
|
|
| Tubulysin M |
|
|
|
|
|
|
|
|
98.74% |
| Daunorubicin-13C,d3 TFA |
|
|
|
|
|
|
|
|
|
| Daunorubicin |
|
|
|
|
|
|
|
|
99.94% |
| Daunorubicin citrate |
|
|
|
|
|
|
|
|
|
| Thailanstatin A |
|
|
|
|
|
|
|
|
99.09% |
| Auristatin E |
|
|
|
|
|
|
|
|
99.86% |
| Auristatin F |
|
|
|
|
|
|
|
|
99.96% |
| Methotrexate-d3 |
|
|
|
|
|
|
|
|
99.83% |
| Methotrexate |
|
|
|
|
|
|
|
|
99.95% |
| Methotrexate monohydrate |
|
|
|
|
|
|
|
|
|
| Methotrexate disodium |
|
|
|
|
|
|
|
|
99.63% |
| Daunorubicin hydrochloride |
|
|
|
|
|
|
|
|
99.67% |
| Doxorubicin hydrochloride |
|
|
|
|
|
|
|
|
99.90% |
| Piericidin A |
|
|
|
|
|
|
|
|
99.83% |
| Paclitaxel-d5 |
|
|
|
|
|
|
|
|
99.9% |
| Paclitaxel-d5 (benzoyloxy) |
|
|
|
|
|
|
|
|
|
| 10-Acetyl docetaxel |
|
|
|
|
|
|
|
|
99.54% |
| Mertansine-13C,d3 |
|
|
|
|
|
|
|
|
|
| Maytansinol |
|
|
|
|
|
|
|
|
99.32% |
| Eribulin |
|
|
|
|
|
|
|
|
99.46% |